Searched for
OMICRON VACCINE TRIAL
India may not change its Covid vaccination plan: Official"We are doing well with the present strategy and hence there is no need to make changes in the vaccination programme, which is already work...- Drug panel may review Gennova's mRNA Omicron booster vaccinePune-based Gennova Biopharmaceuticals had submitted data to the drug regulator this month, amid an increase in the number of Covid-19 cases...
- Gennova Biopharma seeks DCGI nod for its Omicron boosterGennova has developed an Omicron specific vaccine GEMCOVAC-OM which has been assessed for its safety and immunogenicity when administered a...
- Gennova eyes nod for omicron-specific vaxAs Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...
- Molnupiravir doesn't help reduce deaths or hospital admissions: StudyPrevious studies among unvaccinated patients had suggested that molnupiravir could help prevent hospital admission. The latest study provid...
- Moderna seeks US FDA approval for Omicron Covid booster for children over 6 yearsIn a request to the Food and Drug Administration (FDA), Boston-based biotech has requested that omicron shots be approved for teenagers age...
- SII is working on an Omicron-specific vaccine, may launch it by the end of this year: ReportSII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further...
- Variant-adapted Covid vaccine wins first approval in BritainThe UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults. The ag...
- Sanofi, GSK variant-specific Covid-19 shot found effective against Omicron"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron varian...
- Moderna's new booster produces stronger response against OmicronModerna has been studying the so-called bivalent vaccine, which targets both Omicron and the original coronavirus strain to determine if it...
- India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: StudyThe heat-tolerant COVID-19 vaccine candidate can be stored at 37 degrees Celsius for four weeks and at 100 degrees Celsius for up to 90 min...
- Gennova Biopharmaceuticals developing Omicron specific vaccineGennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...
- Pfizer, BioNTech begin vaccine trial to target new strainThe study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...
- Pfizer-BioNTech begin trials of new vaccine against Omicron variantThe study will have 1420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech COVID vaccine or an Omicr...
- Pfizer-BioNTech begin Omicron vaccine trialPfizer's CEO Albert Bourla has previously said that the pharmaceutical giant could be ready to file for regulatory approval of the shot by ...
- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- Vaccination drive needs to be strengthened globally; pandemic treaty being discussed: WHO chief scientistDr Soumya Swaminathan said that discussions are taking place at the global level about having a "pandemic treaty" which binds all the count...
- Sputnik Light booster works against OmicronGamaleya said it expects Sputnik V to provide a strong defence against severe disease and hospitalisation, as the drop in neutralising acti...
- How effective are vaccines against omicron, does booster dose works? Find all answers hereDespite the lowered effectiveness of vaccines against omicron, it is clear that vaccines do work and are among the greatest public health a...
- Testing a new jab on fresh strain, says AstraZenecaThe company, along with Oxford University, has developed a vaccine platform to enable it to respond quickly to new variants that may emerge.
Load More
